Pushkin.

It's hard to read the news these days without asking yourself, how did we get here?

Fiasco is a history podcast for the co-creators of Slow Burn.

In our first season, Bush v. Gore, we examined an unmistakable turning point in American

politics, the 2000 election, which resulted in a high-stakes stalemate, ended with one of the most

controversial rulings in Supreme Court history.

So if you're trying to make sense at the present moment, check out Fiasco, Bush v. Gore.

Listen on the Iheart radio app, Apple Podcasts, or wherever you listen to podcasts.

From Pushkin Industries, this is Deep Background, the show where we explore the stories behind the stories in the news.

I'm Noah Feldman. Research into the novel coronavirus is happening and being published or sometimes just press released at breakneck speed.

Every few weeks we hear about a possible new breakthrough or a potentially interesting avenue of research.

But often that breakthrough turns out to be too good to be true or to have less effect than we might have imagined.

To help us make sense of the latest about the novel coronavirus, which studies to watch, which studies are too soon to interpret and where we are in the progress towards a vaccine, we're joined by Dr. Saad Omer.

Dr. Omer is a professor of infectious disease and epidemiology at the Yale School of Medicine

and at the Yale School of Public Health.

He's also director of the Yale Institute for Global Health.

In short, he's perfectly qualified to talk about these questions.

Saad, thank you so much for joining me. I'm very grateful. I wonder if we could begin with some of the latest publicized developments in therapy.

There's a large randomized study out of the UK, which we only have seen so far in press release form, although we're getting used to that,

involving the use of the steroid dexamethyone.

What is your takeaway from that study?

It's a very encouraging study for several reasons.

...